Stock listing

NASDAQ:OCAT Ocata Therapeutics Inc Stock

Follow Ocata Therapeutics Inc into a list and get an email when it puts out news.

Last close · NASDAQ:OCAT

$8.47 USD

Close on Feb 9, 2016 · No longer trades

Feb 17, 2005 to last close -98.6% · monthly closes, Feb 17, 2005 – Feb 9, 2016
Lowest – highest close
$1.00 – $700.00 USDSince Feb 17, 2005 · lowest Jul 28, 2008 · highest Feb 18, 2005

Delisted NASDAQ:OCAT no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:OCAT
Asset type
Stock
Exchange
NASDAQ
Currency
USD

Ocata Therapeutics Inc on 6ix

Decks
3 decks · latest Feb 9, 2015

Decks

DeckKindSlidesDate
BIO CEO Presentation (February 2015)Conference32 slidesFeb 9, 2015
IPO Roadshow (December 2014)IPO roadshow32 slidesDec 19, 2014
Advanced Cell Technology — Investor Presentation (July 2007)Investor deck55 slidesJul 2, 2007

Open Decks

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Robert Langer
Other companies: Seer, Inc. (Director · Since at least Dec 3, 2020); Lyra Therapeutics, Inc. (David H. Koch Institute Professor, Massachusetts Institute of Technology · Since at least Apr 30, 2020); Korro Bio, Inc. (Director · Oct 2, 2019 – Aug 17, 2022 · Past); Moderna, Inc. (Director · Dec 7, 2018 – May 6, 2024 · Past); Rubius Therapeutics Inc (Director · Jul 17, 2018 – Oct 14, 2019 · Past); Kala Bio, Inc. (Director · Jul 19, 2017 – Jun 12, 2018 · Past); BIND Therapeutics Inc (Director · Sep 19, 2013 – Jun 21, 2016 · Past)
Director · Oct 4, 2011 – Feb 10, 2016 · Past
Michael D West
Other companies: Serina Therapeutics, Inc. (Chief Executive Officer · Nov 27, 2018 – Mar 11, 2023 · Past); Insight Molecular Diagnostics Inc. (Director · Dec 30, 2015 – Feb 16, 2016 · Past); Asterias Biotherapeutics Inc (VP of Technology Integration, Director · Feb 13, 2015 – Feb 13, 2015 · Past); Lineage Cell Therapeutics, Inc. (Co-Chief Executive Officer, Director · Dec 31, 2005 – Sep 17, 2018 · Past)
Director · Oct 9, 2007 – Oct 9, 2007 · Past
Paul Wotton
Other companies: Vericel Corporation (Director · Since at least Jan 6, 2015); Genaera Corp (Director · Jun 26, 2008 – Aug 13, 2008 · Past); Antares Pharma Inc (President and CEO, Director · Jan 3, 2006 – May 29, 2014 · Past)
President and CEO, Director · Jul 21, 2014 – Feb 10, 2016 · Past
Pedro Huertas
Other companies: Inozyme Pharma Inc (SVP, CMO · Jul 23, 2020 – Jan 13, 2021 · Past)
Chief Development Officer · Feb 5, 2007 – Sep 7, 2007 · Past

Open People

Log in to ask 6ix AI your own questions about Ocata Therapeutics Inc.